- Home
- / Advanced Oncotherapy
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Advanced Oncotherapy financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|
| Cost of goods sold | 1.9M | |||
| Gross profit | (1.9M) | |||
| Operating expense total | 19.2M | 18.4M | 17.5M | 21.3M |
| Depreciation and amortization | 411.0K | 2.0M | 2.3M | 2.3M |
| EBITDA | (21.1M) | (18.4M) | (17.5M) | (21.3M) |
| EBIT | (21.5M) | (20.4M) | (19.8M) | (23.6M) |
| Interest income | 13.0K | 15.0K | 3.0K | |
| Interest expense | 80.0K | 1.2M | 4.2M | 5.6M |
| Pre tax profit | (21.9M) | (21.9M) | (25.3M) | (29.5M) |
| Income tax expense | (759.0K) | (1.1M) | ||
| Net Income | (21.2M) | (20.8M) | (25.3M) | (29.5M) |